Rani Therapeutics (RANI) traded up 3.06 % during a 24 hours period ending at 09:59 PM Central Europe on Monday 26th. One Rani Therapeutics stock can currently be bought for about USD 0.62 on popular exchanges. Current supply of Rani Therapeutics stocks is 115.4 mn. Rani Therapeutics has a current market capitalization of USD 85.1 mn and approximately USD 174.6 k worth of Rani Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Rani Therapeutics has traded -19.09 % down. Simple moving average of last 200 days is at USD 0.95. The highest price of past 52 weeks was recorded at USD 2.63 on 11/06/2025. 52 weeks low was at USD 0.57 on 10/22/2026.
Here is how related stocks have performed in the past 24 hours:
Tcgx Acquisition (TCGX) traded up 0.7 % and now trades at USD 10.14. Tcgx Acquisition has a market capitalisation of USD 99.7 mn.
Onkure Therapeutics (OKUR) traded down -2.33 % and now trades at USD 2.48. Current market capitalisation for Onkure Therapeutics is USD 101.8 mn.
Vaxart (VXRT) traded down -2.17 % and now trades at USD 0.4. Current market capitalisation for Vaxart is USD 99.7 mn. Vaxart has a current price to earnings ratio of 2.65.
Vivani Medical (VANI) traded up 1.83 % and now trades at USD 1.13. Current market capitalisation for Vivani Medical is USD 100.1 mn.
Apyx Medical (APYX) traded down -1.66 % and now trades at USD 2.46. Current market capitalisation for Apyx Medical is USD 99.8 mn.
About Rani Therapeutics
Rani Therapeutics Holdings, Inc. is a health care sector company based in San Jose, United States, that operates as a holding company. Through its subsidiaries, it focuses on developing oral administered biologics to revolutionize medicine and improve patient outcomes. Rani Therapeutics Holdings serves customers in the United States and can be accessed online through their webseite at www.ranitherapeutics.com . The company is listed on the Nasdaq stock exchange.
